Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Weill Cornell Colg

Neither a doctor nor a teaching hospital

Research payments

$1,369,907

91 payments

Through program year 2025, Weill Cornell Colg is reported as receiving $1,369,907 in research payments, across 91 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $580,578 46
2024 Research $707,913 35
2023 Research $81,417 10

Breakdown

Who paid Research payments · program years 2023–2025
  1. Janssen Research & Development, LLC $1,369,907 91 payments
Studies the money was for Research payments · program years 2023–2025
  1. Arx517-2011 $361,147 5 payments
  2. A Phase 1, Multicenter, Open-Label, Dose-Escalation, and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of ARX517 as Monotherapy and in Combination With Androgen Receptor Pathway Inhibitors in Subjects With Metastatic Prostate Cancer $275,682 7 payments
  3. 70033093Afl3002 $242,154 17 payments
  4. A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation $188,797 17 payments
  5. 70033093Str3001 $107,141 18 payments
  6. A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) $47,263 11 payments
  7. Platformpbcrd3001 $40,752 2 payments
  8. A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) $39,710 9 payments
  9. 70033093Acs3003 $38,136 3 payments
  10. A Phase 3, Multicenter, Randomized Clinical Study to Evaluate Mirikizumab in Pediatric Crohn's Disease $29,126 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record